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Abstract
We aimed to characterize the incidence, clinical features, risk factors and outcomes of recurrent late-onset sepsis (LOS) in the
neonatal intensive care unit (NICU). All neonates with LOS from the NICU of a tertiary-level teaching hospital in northern Taiwan
between 2004 and 2011 were enrolled for analyses. A case-control study was performed to determine risk factors for recurrence. Of
713 neonates with LOS, 150 (21.0%) experienced recurrence and 48 (6.7%) had >1 recurrences; c. two-thirds of recurrent LOS
occurred in infants with birth weight (BW) ≦ 1500 g or gestational age (GA) ≦ 30 weeks. The recurrent LOS episodes were
signiﬁcantly more severe and had a higher sepsis-attributable mortality rate than the ﬁrst episodes. The overall in-hospital mortality
rate was 30.7% for neonates with recurrent LOS and 7.8% for those with single LOS (odds ratio (OR), 5.22; 95% CI, 3.28–8.30). When
both BW and GA were controlled, neonates with recurrent LOS had a signiﬁcantly prolonged hospitalization compared with the
controls (median 109 vs. 84 days, p <0.001). After multivariate logistic regression, longer duration of total parenteral nutrition (TPN;
OR, 1.30; 95% CI, 1.10–1.52 for every 10-day increment), presence of congenital anomalies (OR, 2.64; 95% CI, 1.10–6.35) and
neurological co-morbidities (OR, 4.14; 95% CI, 1.14–15.10) were identiﬁed as the independent risk factors for LOS recurrence. We
concluded that c. one-ﬁfth of neonates with LOS had recurrence, which signiﬁcantly resulted in prolonged hospitalization and increased
mortality. Longer TPN administration, presence of congenital anomalies and neurological co-morbidities are independently associated
with recurrent LOS.
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Introduction
Although advances in perinatal resuscitation and neonatal care
have led to improved survival of high-risk neonates in the
neonatal intensive care unit (NICU), late-onset sepsis (LOS)
remains an important cause of morbidity and mortality [1–3].
A signiﬁcant percentage of neonates experience one or
more episodes of blood culture-proven LOS during their
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hospitalization [2,4,5], and there have been a number of
studies focused on the epidemiology, microbiology, clinical
characteristics, risk factors and outcomes of LOS [1–7].
Recent studies extended the long-term outcome investigation
and found that LOS is highly associated with poor neurode-
velopmental delay and growth impairment during early child-
hood [8,9].
However, most neonatal LOS studies ignored an important
outcome of LOS, the repeated episode(s), and only the ﬁrst
episode for each infant was retrieved for analysis [1,3,6,10–12].
Recurrent LOS deserves greater awareness because most
neonates survive the primary infection and those who
potentially experience a repeated episode may have a
prolonged hospital stay and higher mortality rate. Recurrent
bacteraemia has been concluded to be an independent risk
factor for mortality [13], and risk factors for recurrence were
identiﬁed in several studies [13–16]. In the neonatal setting,
23.7–28% of very low birth weight (VLBW; birth
weight < 1500 g) infants were reported to have recurrent
LOS [4,5], but the clinical impact and risk factors for
recurrence are still unknown. We therefore conducted this
study in order to determine the incidence, clinical character-
istics, risk factors and outcomes of recurrent LOS in the
NICU.
Patients and Methods
Study population
Through our database search, all neonates admitted to the
NICU of Chang Gung Memorial Hospital (CGMH) between
January 2004 and December 2011 were enrolled for analysis if
they had one or more episodes of LOS. This database was
managed by the trained research nurses, who entered the
detailed data regarding the hospitalized infants, including
maternal demographics, pregnancy, delivery information and
the hospital course of the infants, from birth/admission to
discharge/death from the year 2003. This study was approved
by the institutional review board of Chang Gung Memorial
Hospital (CGMH).
Deﬁnition
Late-onset sepsis was deﬁned as a positive blood culture
obtained after 72 h of life in the presence of clinical septic
symptoms and intent to treat with antibiotics for 5 days or
more. Blood cultures positive for the microorganisms, includ-
ing Bacillus, Corynebacterium, Propionibacterium, Penicillium and
Diphtheroids were considered to be contaminants and excluded
from analysis. Records of patients with blood culture positive
for coagulase-negative staphylococci (CoNS) were reviewed,
and the strict criteria from the Centers for Disease Control
and Prevention for CoNS LOS were applied [5,17,18]. The
presence of clinical septic symptoms required at least two of
the following: fever or hypothermia, hyper- or hypoglycaemia,
apnoea or tachypnoea, frequent desaturation with increased
requirement of ventilator support, bradycardia and/or cyano-
sis, feeding intolerance, abdominal distension, seizure,
decreased activity, skin mottling and hypotension. If the same
pathogen was identiﬁed after 14 days of appropriate antibiotic
therapy or after 7 days of appropriate antibiotic therapy and at
least one negative blood culture, or if a different pathogen was
identiﬁed from a subsequent culture 7 days after the ﬁrst one,
it was considered as a recurrent episode of LOS [4,5]. If more
than one microorganism was identiﬁed from a single set of
blood cultures or from different sets within a 48-h period, it
was deﬁned as a polymicrobial LOS episode [19,20].
All co-morbidities of prematurity, including respiratory
distress syndrome (RDS), intraventricular haemorrhage (IVH),
bronchopulmonary dysplasia (BPD), necrotizing enterocolitis
(NEC) and periventricular leukomalacia (PVL), were based on
the latest updated diagnostic criteria in the standard textbook
of neonatology [21]. Severity of illness was evaluated at the
most severe period during the course of each LOS episode by
two investigators (S-MC and J-FH) using the neonatal thera-
peutic intervention scoring system (NTISS) [22]. For patients
who died during hospitalization, the cause of death was
recorded according to the clinician’s presumption, and mor-
tality was considered attributable to the episode of LOS if the
patient died within 7 days of the onset of LOS or in the
presence of persisting clinical sepsis or bacteraemia; otherwise
death was considered unrelated to the episode of LOS.
Statistical methods
All episodes of LOS were considered independently. Statistical
signiﬁcance for unadjusted comparisons between the ﬁrst
episode of LOS and recurrent episodes of LOS was deter-
mined by the chi-squared or Fisher exact test for categorical
data, and the Student’s t-test or the Wilcoxon/Mann–Whitney
test for continuous variables. Tests were two-sided and a p
value <0.05 was considered signiﬁcant.
To assess risk factors for the development of recurrence,
we conducted a matched case-control study by selecting one
control with single LOS for each case with recurrent LOS. This
control was matched to each case using birth weight (BW;
100 g) and gestational age (GA; 1 week). The association
between the different variables analysed and recurrence was
estimated by calculating the odds ratio (OR) for the univariate
analysis. Finally, a multivariate logistic regression model
consisting of those variables that were signiﬁcantly associated
with recurrence at a p value of <0.05 by univariate analysis was
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developed using a sequential approach and then removing
insigniﬁcant covariates. All statistics were performed using the
commercially available software SPSS 16.0 for Windows
(SPSS, Chicago, IL, USA).
Results
Incidence of LOS and recurrent LOS
During the study period, a total of 5233 neonates had been
admitted to our NICUs. After excluding 223 neonates, of whom
181 neonates died within the ﬁrst 3 days of life and 42
transferred to other hospitals before discharge, there were 942
episodes of LOS in 713 neonates among the cohort of 5010
neonates. Of them, 150 (21.0%) had more than one episode
(recurrence) of LOS with a mean of 2.52 episodes per patient.
Forty-eight (32.0%) of 150 neonates had more than two
episodes of LOS. The incidence of a single recurrence (only
two LOS episodes) during follow-up was 14.3%, whereas the
incidence of a third or further episode was signiﬁcantly higher in
patients with a ﬁrst recurrent episode of LOS (32.0%; p <0.05).
One hundred and ﬁfty-ﬁve (67.7%) and 159 (69.4%) episodes
of recurrent LOS occurred in neonates with GA ≤30 weeks
and VLBW infants, respectively. The rates of both LOS and
recurrent LOS were inversely proportional to BW and GA.
However, the incidence rates of overall, ﬁrst and recurrent
episodes of LOS did not decrease with BW or GA (Fig. 1). The
overall BW- and GA-adjusted incidence rate of LOS was 37.1
(95% CI, 33.1–41.2) per 10 000 neonatal-hospital days, includ-
ing 28.1 (95% CI, 24.3–31.9) per 10 000 neonatal-hospital days
for ﬁrst episodes and 9.0 (95% CI, 7.4–10.6) per 10 000
neonatal-hospital days for recurrent episodes. Among 150
(a)
(b)
FIG. 1. The rates and incidence rates of
late-onset sepsis and recurrent late-onset
sepsis in the neonatal intensive care unit,
2004–2011, stratiﬁed by birth weight (a)
and gestational age (b; sample sizes were
listed above the histogram).
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neonates with recurrent LOS, 97 (64.7%) ﬁrst recurrent
episodes occurred within 30 days of the ﬁrst LOS, and the
median time to recurrence was 24 days (IQR, 15–42.3). The
time-frame for second recurrence was similar to the ﬁrst one
(61.2% within 1 month; median time to recurrence, 23 days;
IQR, 12–44.5). The estimated cumulative incidence rates of
recurrence were 13.6% and 19.8%, respectively, for 1 month
and 3 months after the ﬁrst episode of LOS, and were 20.0%
and 31.3%, respectively, for the second recurrence (p 0.001 by
log rank test with the Kaplan–Meier method, Fig. 2).
Clinical characteristics of recurrent LOS
The clinical characteristics and outcomes of the ﬁrst and
recurrent episodes of LOS are shown in Table 1. Neonates
with recurrent LOS had signiﬁcantly lower birth weight and
gestational age than those with single episode of LOS (median
1050 g, interquartile range (768–1685) vs. 1400 (1040–2070)
and 28.0 weeks (26.0–33.3) vs. 31.0 weeks (28.0–35.0),
respectively, both p <0.001). While some of the ﬁrst episodes
of LOS were community acquired, all the recurrent episodes
of LOS were exclusively nosocomial infection and signiﬁcantly
more frequently occurred in neonates with underlying chronic
conditions, presence of CVC, mechanical ventilations and use
of TPN or intrafat (all p <0.001).
The proportion of Gram-positive bacteraemia was lower in
recurrent episodes compared with ﬁrst episodes (48.0% vs.
61.0%, p 0.001). Most clinical manifestations, including fever,
apnoea or cyanosis, hypoglycaemia, and feeding intolerance,
were comparable between the ﬁrst episode and the recurrent
episode of LOS (data not shown). However, the recurrent
episode of LOS seemed to be more severe and likely to have
deteriorated conditions than the ﬁrst episode of LOS, as the
patients with a recurrent episode had signiﬁcantly higher rates
of septic shock, disseminated intravascular coagulopathy,
haematological abnormalities requiring blood transfusion, and
requirement of invasive intubation for oxygenation support,
and higher severity of illness (as judged by NTISS scores;
Table 1).
Forty-six of 150 (30.7%) neonates with recurrent LOS died,
which was signiﬁcantly higher than those with a single episode
FIG. 2. Cumulative incidence rates of ﬁrst and second recurrent
late-onset sepsis (LOS) by time since the previous episodes (in weeks)
with follow-up censored at death.
TABLE 1. Demographics, pathogens, clinical manifestations
and outcomes of ﬁrst and recurrent episodes of late-onset
sepsis in the neonatal intensive care unit
Variable
First episodes
(n = 713)
Recurrent
episodes
(n = 229) p Value
Birth body weight (g),
median (IQR)
1342.5
(959.5–2030.0)
1040.0
(767.5–1690.0)a
<0.001
Gestational age (weeks),
median (IQR)
30.0 (27.0–35.0) 28.0 (26.0–33.5)a <0.001
Gender (male/female) 388/325 (54.4/45.6) 69/81 (46.0/54.0)a 0.058
Vaginal delivery/
Caesarean section
298/415 (41.8/58.2) 71/79 (47.3/52.7)a 0.237
Inborn/outborn 467/246 (65.5/34.5) 101/49 (67.3/32.7)a 0.776
Presence of central
venous catheterb
558 (78.3) 213 (93.0) <0.001
Use of TPN and/or
intrafatb
510 (71.5) 193 (84.3) <0.001
Mechanical ventilation
with intubationb
102 (14.3) 67 (29.3) <0.001
Under high-frequency
oscillatory ventilationb
36 (5.0) 18 (7.9) 0.231
Microbiology, total n (%) 713 (100) 229 (100)
Monomicrobial
Gram-positive organisms
435 (61.0) 110 (48.0) 0.001
Monomicrobial
Gram-negative organisms
221 (31.0) 86 (37.5) 0.089
Fungus 32 (4.5) 20 (8.7) 0.019
Polymicrobial organisms 25 (3.5) 13 (5.7) 0.174
Clinical manifestations
Septic shock 109 (15.3) 49 (21.4) 0.032
Disseminated
intravascular
coagulopathy
53 (7.4) 31 (13.5) 0.007
GI bleeding and/or
coagulopathy
179 (25.1) 61 (26.6) 0.602
Haematological
abnormalitiesc
215 (30.2) 112 (48.9) <0.001
NTISS scored,
median (IQR)
17.0 (14.0–20.0) 19.0 (15.0–21.0) 0.012
Treatment
Requirement of invasive
ventilator (intubation)
294 (41.2) 122 (53.3) 0.001
Requirement of HFOV
and/or iNO
62 (8.7) 27 (11.8) 0.115
Empirically treated with
three-combined
antibiotics
41 (5.8) 22 (9.6) 0.047
Outcomes
Infectious
complicationse
78 (10.9) 28 (12.2) 0.631
Sepsis-attributable
mortality
30 (4.2) 38 (16.6) <0.001
Overall in-hospital
mortality
90/713 (12.6) 46/150 (30.7) <0.001
All data were expressed as number (percentage, %), unless indicated otherwise.
NTISS, Neonatal Therapeutic Intervention Scoring System; HFOV, high-frequency
oscillatory ventilator; iNO, inhalation of nitric oxide; IQR, interquartile range;
TPN, total parenteral nutrition.
aResults for 150 unique neonates with recurrent late-onset sepsis.
bIndicated at onset of late-onset sepsis.
cIndicating requirement of blood transfusion with red blood cells, platelets or fresh
frozen plasma.
dNTISS scores the most intense level during the episode of late-onset sepsis.
eIncluding any newly infectious focus and major organ damage after late-onset
sepsis, but not occurring concurrently.
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of LOS (44 of 563 neonates, 7.8%; OR, 5.22; 95% CI, 3.28–
8.30; p <0.001). The sepsis-attributable mortality rate for
recurrent LOS was also signiﬁcantly higher than that for the
ﬁrst episode of LOS (16.6% vs. 4.2%, p <0.001).
Risk factors for recurrence
Because neonates with recurrent LOS had signiﬁcantly lower
BW and GA, which were undoubtedly the confounders for
recurrence due to prolonged hospitalization, we selected
matched BW and GA neonates with single LOS (the controls)
for each case with recurrent LOS. Also, the proportion of the
pathogens in the controls was comparable to that in general
LOS (Table 2).
Compared with the matched controls, the cases with
recurrent LOS had signiﬁcantly higher rates of underlying
congenital anomalies, neurological co-morbidities and BPD
(Table 2). Also, female gender was associated with higher risk
of recurrent LOS, which was also noted for the entire cohort
with LOS. The pathogens, the antimicrobial agents used and
the severity of illness for the ﬁrst episode of LOS (as judged by
NTISS scores) did not affect the recurrence of LOS, but the
presence of infectious complications after the ﬁrst LOS was
associated with a relatively higher risk of recurrent LOS (p
0.055). Neonates with longer duration of CVC use, TPN
administration and mechanical ventilation with intubation were
all signiﬁcantly associated with a higher risk of recurrence (all
p ≤0.001 by univariate analysis), but nasal continuous positive
airway pressure use was comparable between the case and
control groups.
The case group had signiﬁcantly longer duration of hospi-
talization than the controls (median (IQR) of 109.0 days (78.8–
153.0) vs. 84.0 days (48.0–107.0) days, p <0.001). After
multivariate logistic regression analysis, underlying congenital
anomalies (OR, 2.64; 95% CI, 1.10–6.35; p 0.030) and
neurological co-morbidities (OR, 4.14; 95% CI, 1.14–15.10; p
0.031) and longer duration of TPN administration (OR, 1.30;
95% CI, 1.10–1.52; p 0.002 for every 10-day increment) were
identiﬁed as the independent risk factors for recurrence.
Discussion
The present study suggests that a substantial proportion of
neonates with LOS, up to one-ﬁfth, may have recurrent LOS.
For neonates with recurrent LOS, nearly one-third had a
third episode of LOS (second recurrence). Recurrent LOS is
associated with more severe clinical symptoms and neonates
with recurrent LOS are associated with a signiﬁcantly longer
TABLE 2. Risk factors for recurrence by comparisons of demographic, clinical and epidemiological features of cases with
recurrent late-onset sepsis and matched controls with single episode of late-onset sepsis
Variables
Univariate analysis Multivariate analysis
Case (n = 150), n (%) Controls (n = 150), n (%) p value OR (95% CI) p value
Birth weight (g), median (IQR) 1050 (768.8–1685) 1067 (785–1740) 0.979
Gestational age (weeks), median (IQR) 28.0 (26.0–33.2) 28.0 (26.0–33.0) 0.822
Gender (male/female) 69/81 (46.0/54.0) 88/62 (58.7/41.3) 0.037 1.67 (0.98–2.83) 0.059
Presence of underlying conditionsa
Congenital anomalies 18 (12.0) 4 (2.7) 0.003 4.14 (1.14–15.10) 0.031
Bronchopulmonary dysplasia 98 (65.3) 76 (50.7) 0.014 1.18 (0.63–2.23) 0.603
Neurological co-morbidities 30 (20.0) 10 (6.7) 0.001 2.64 (1.10–6.35) 0.030
Chronic GI pathology 14 (9.3) 10 (6.7) 0.524
Cardiovascular disorders 7 (4.7) 5 (3.3) 0.770
Pathogen of ﬁrst episode of LOS
Monomicrobial Gram-positive 88 (58.7) 90 (60.0) 0.380
Monomicrobial Gram-negative 42 (28.0) 48 (32.0)
Polymicrobial 7 (4.7) 6 (4.0)
Fungus 13 (8.7) 6 (4.0)
NTISS of ﬁrst episode LOS 19.0 (15.0–21.0) 17.0 (15.0–20.0) 0.143
Management of ﬁrst episode of LOS
Initial appropriate antibioticsb 107 (71.3) 105 (70.0) 0.899
Removal of CVC within 3 days 49/144 (34.0) 53/148 (35.8) 0.806
Presence of infectious complicationsa 25 (16.7) 13 (8.7) 0.055 1.56 (0.69–3.52) 0.286
Duration of CVC (days), median (IQR) 60.0 (40.0–89.0) 32.0 (18.8–46.0) <0.001
Every 10-day increment 1.10 (0.94–1.28) 0.227
Duration of intubation (days) 47.0 (16.0–78.5) 25.5 (5.0–63.0) 0.001
Every 10-day increment 0.95 (0.86–1.05) 0.285
Duration of nasal ventilatorc (days) 10.5 (1.0–30.0) 9.0 (1.0–25.0) 0.627
Duration of TPN (days), median (IQR) 57.0 (34.0–83.0) 28.5 (15.8–46.0) <0.001
Every 10-day increment 1.30 (1.10–1.52) 0.002
Duration of hospitalization (days) 109.0 (78.8–153.0) 84.0 (48.0–107.0) <0.001
All data were expressed as number (percentage, %), unless indicated otherwise. LOS, late-onset sepsis; NTISS, Neonatal Therapeutic Intervention Scoring System; CVC, central
venous catheter; IQR, interquartile range; TPN, total parenteral nutrition.
aAfter ﬁrst episode of LOS, each patient with an underlying chronic condition was compared with those without that speciﬁc condition; infectious complications included any
newly infectious focus and major organ damage after late-onset sepsis, but not occurring concurrently.
bIndicated administration of antimicrobial agents to which the causative microorganisms were susceptible in vitro within the ﬁrst 24 h of LOS onset.
cIncluding nasal intermittent mandatory ventilator (N-IMV) and nasal continuous positive airway pressure (N-CPAP).
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hospital stay and a higher mortality rate. Although recurrent
LOS is more common in extremely preterm or VLBW
infants, a longer duration of TPN use, underlying congenital
anomalies and neurological co-morbidities are the indepen-
dent risk factors for recurrence of LOS after adjusting for
BW and GA.
Our results are consistent with those reported by Makhoul
et al. and Stoll et al. [4,5], who found a recurrence rate of
23.8–28% in VLBW infants. Although both rates of LOS and
recurrence were inversely correlated with BW and GA, we
found that the incidence rates of LOS and recurrent LOS were
comparable between extremely preterm and late-preterm
neonates. In contrast to previous studies that focused on
selected groups of neonates and ignored the inﬂuences of
recurrent LOS [1,4,6], our study is of greater value and
included all high-risk neonates in the NICU. We also found
that there have been signiﬁcantly different pathogens and
clinical characteristics between the ﬁrst and recurrent epi-
sodes of LOS. Also, in neonates with an established recur-
rence, the Kaplan–Meier method documented that these
patients were signiﬁcantly more likely to have more recur-
rences (Fig. 2).
Previous studies identiﬁed the associations between neo-
natal LOS and mechanical ventilation, the use and duration of
TPN and CVCs [6,23–25]. It is reasonably presumed that
these variables were also associated with the occurrence of
further LOS episodes after the ﬁrst episode of LOS. Further
analysis revealed that there was a convincing dose-response
relationship between recurrent LOS and these three vari-
ables. However, only the duration of TPN was found to be an
independent risk factor in the multivariate model. These
results support the evidence of a beneﬁcial effect of early
enteral feeding in preventing neonatal sepsis [24] and could
explain why the recurrent episode of LOS was less commonly
caused by normal skin ﬂora such as CoNS. TPN has been
identiﬁed as a signiﬁcant risk factor for ICU healthcare-asso-
ciated infection, especially candidaemia and Gram-negative
bacteraemia [25,26], but the mechanisms need further
studies.
In the present study, we found that congenital anomalies
and neurological co-morbidities were the independent risk
factors, which was consistent with previous studies [13–
16,27,28]. While neither the pathogens, the antimicrobial
agents used nor the severity of illness in ﬁrst episode of LOS
affect the recurrence of LOS, the presence of infectious
complications after the ﬁrst LOS was associated with a higher
risk of recurrent LOS. Altogether, these suggest that after the
ﬁrst LOS, it is the patient’s conditions, including underlying or
newly chronic diseases and use of mechanical devices, which
determines whether the patient will encounter further
episodes of LOS. In addition, the pathogens responsible for
the second episode of LOS were often different from those
responsible for the ﬁrst episodes (107 of 150 episodes, 71.3%),
which meant most recurrence in the NICU is re-infection
rather than relapse of initial episodes.
The present study also indicated that recurrent LOS in the
NICU was signiﬁcantly associated with a more severe illness, a
higher rate of septic shock, haematological abnormalities and
sepsis-attributable mortality. These ﬁndings were not reported
in other settings [13–16,27,28], although recurrent bactera-
emia was found to be the independent risk factor for mortality
in one study [13]. This can be explained by several reasons. In
the NICU, recurrent LOS is more frequently caused by
Gram-negative bacilli or fungus, which are associated with a
more severe illness and higher risk of mortality [4,5]. Selection
by previous antibiotic treatment for ﬁrst episode LOS may
result in the colonized ﬂora or gastrointestinal tract bacteria
becoming antimicrobial-resistant bacteria [29,30], which are
associated with more severe infection if appropriate antibiotics
are not received. Also, neonates with suboptimal conditions
and medical devices are especially vulnerable to one more
episode of LOS, which worsens the patient’s clinical condition
and contributes to mortality.
This study had some limitations. The study population was
from a single medical centre, and the results may be less
generalizable than those from multicentre studies with a
prospective observational design. Some potential risk factors
were not collected and examined, such as the length of
previous antimicrobial administration and use of corticoste-
roid, which may possibly affect the colonized ﬂora on the
neonates’ skin and the risk of recurrent LOS. Neonatal clinical
sepsis (without positive blood culture proven) was not
considered, which actually underestimated the incidence of
recurrent LOS. Finally, because the controls were matched to
cases by BW and GA, we are unable to make conclusions
about the importance of prematurity or low BW as a risk
factor.
In conclusion, recurrent LOS is not uncommon in neonates
with LOS and affects those with certain chronic conditions in
particular. Because prolonged use of TPN is independently
associated with higher risk of recurrent LOS, early enteral
feeding is encouraged and the risks and beneﬁts of TPN
administration should be considered. Given the higher severity
of illness and a higher sepsis-attributable mortality rate, further
studies are needed to better deﬁne populations amenable to
interventions in order to avoid recurrences. In patients with an
established recurrence, the issue of whether these neonates
would beneﬁt from broad-spectrum antimicrobial therapy or
more aggressive therapeutic modalities should be further
deﬁned to reduce mortality.
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